USD 263.49
(0.46%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.55 Billion USD | 13.53% |
2022 | 1.37 Billion USD | 10.18% |
2021 | 1.24 Billion USD | 51.19% |
2020 | 822.98 Million USD | 23.59% |
2019 | 665.9 Million USD | 29.3% |
2018 | 515 Million USD | 8.04% |
2017 | 476.66 Million USD | 54.63% |
2016 | 308.25 Million USD | 16.83% |
2015 | 263.84 Million USD | 117.37% |
2014 | 121.38 Million USD | 70.61% |
2013 | 71.14 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.53 Billion USD | -2.87% |
2024 Q3 | 1.47 Billion USD | -3.61% |
2024 Q1 | 1.57 Billion USD | 1.51% |
2023 Q4 | 1.55 Billion USD | 5.99% |
2023 Q2 | 1.43 Billion USD | 2.67% |
2023 Q3 | 1.46 Billion USD | 2.5% |
2023 Q1 | 1.39 Billion USD | 1.78% |
2023 FY | 1.55 Billion USD | 13.53% |
2022 Q2 | 1.32 Billion USD | 2.02% |
2022 FY | 1.37 Billion USD | 10.18% |
2022 Q3 | 1.32 Billion USD | -0.47% |
2022 Q4 | 1.37 Billion USD | 3.73% |
2022 Q1 | 1.3 Billion USD | 4.61% |
2021 Q2 | 910.21 Million USD | 8.25% |
2021 Q1 | 840.82 Million USD | 2.17% |
2021 FY | 1.24 Billion USD | 51.19% |
2021 Q3 | 973.24 Million USD | 6.92% |
2021 Q4 | 1.24 Billion USD | 27.85% |
2020 Q4 | 822.98 Million USD | 1.56% |
2020 Q3 | 810.3 Million USD | 3.86% |
2020 FY | 822.98 Million USD | 23.59% |
2020 Q2 | 780.2 Million USD | 17.46% |
2020 Q1 | 664.24 Million USD | -0.25% |
2019 Q1 | 568.78 Million USD | 10.44% |
2019 Q4 | 665.9 Million USD | 8.42% |
2019 FY | 665.9 Million USD | 29.3% |
2019 Q2 | 585.1 Million USD | 2.87% |
2019 Q3 | 614.17 Million USD | 4.97% |
2018 FY | 515 Million USD | 8.04% |
2018 Q2 | 499.31 Million USD | 1.96% |
2018 Q1 | 489.7 Million USD | 2.74% |
2018 Q4 | 515 Million USD | 2.79% |
2018 Q3 | 501 Million USD | 0.34% |
2017 FY | 476.66 Million USD | 54.63% |
2017 Q1 | 418.36 Million USD | 35.72% |
2017 Q2 | 417 Million USD | -0.33% |
2017 Q3 | 459.09 Million USD | 10.09% |
2017 Q4 | 476.66 Million USD | 3.83% |
2016 FY | 308.25 Million USD | 16.83% |
2016 Q1 | 275.12 Million USD | 4.27% |
2016 Q2 | 283.97 Million USD | 3.22% |
2016 Q3 | 297.27 Million USD | 4.68% |
2016 Q4 | 308.25 Million USD | 3.69% |
2015 Q3 | 259.32 Million USD | 100.92% |
2015 Q1 | 127.41 Million USD | 4.97% |
2015 FY | 263.84 Million USD | 117.37% |
2015 Q4 | 263.84 Million USD | 1.74% |
2015 Q2 | 129.07 Million USD | 1.3% |
2014 Q4 | 121.38 Million USD | 0.0% |
2014 FY | 121.38 Million USD | 70.61% |
2013 FY | 71.14 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Abbott Laboratories | 73.21 Billion USD | 97.874% |
Allurion Technologies Inc. | 71.71 Million USD | -2070.216% |
Artivion, Inc. | 792.39 Million USD | -96.405% |
Avanos Medical, Inc. | 1.69 Billion USD | 8.042% |
Butterfly Network, Inc. | 304.27 Million USD | -411.481% |
Butterfly Network, Inc. | 304.27 Million USD | -411.481% |
Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 87.346% |
Boston Scientific Corporation | 35.13 Billion USD | 95.571% |
CONMED Corporation | 2.3 Billion USD | 32.335% |
Edwards Lifesciences Corporation | 9.36 Billion USD | 83.378% |
Paragon 28, Inc. | 340.69 Million USD | -356.798% |
Glaukos Corporation | 940.41 Million USD | -65.491% |
Globus Medical, Inc. | 5.08 Billion USD | 69.401% |
Inspire Medical Systems, Inc. | 676.81 Million USD | -129.947% |
Integer Holdings Corporation | 2.94 Billion USD | 47.112% |
Medtronic plc | 89.98 Billion USD | 98.27% |
Myomo, Inc. | 14.58 Million USD | -10573.098% |
Nevro Corp. | 635.71 Million USD | -144.813% |
Owlet, Inc. | 44.12 Million USD | -3427.197% |
Vicarious Surgical Inc. | 119.86 Million USD | -1198.392% |
Smith & Nephew plc | 9.98 Billion USD | 84.417% |
Sonendo, Inc. | 78.16 Million USD | -1891.178% |
STERIS plc | 11.06 Billion USD | 85.933% |
Stryker Corporation | 39.91 Billion USD | 96.101% |
Vapotherm, Inc. | 77.61 Million USD | -1905.108% |
Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 92.76% |